Cargando…
Lymphadenectomy in ovarian cancers: a meta-analysis of hazard ratios from randomized clinical trials
BACKGROUND: The debate surrounding systematic lymphadenectomy in the epithelial cancers of the ovary (EOC) was temporarily put to rest by the LION trial. However, there was a glaring disparity between the number of patients registered and the number of patients randomized suggesting inadvertent sele...
Autores principales: | Purwar, Roli, Ranjan, Rakesh, Soni, Kishan, Pandey, Manoj, Upadhyay, Satyanshu K., Pai, Esha, Kumar, Tarun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9682714/ https://www.ncbi.nlm.nih.gov/pubmed/36419077 http://dx.doi.org/10.1186/s12957-022-02835-4 |
Ejemplares similares
-
Role of PARP inhibitors beyond BRCA mutation and platinum sensitivity in epithelial ovarian cancer: a meta-analysis of hazard ratios from randomized clinical trials
por: Purwar, Roli, et al.
Publicado: (2023) -
Tubo-ovarian mass with raised CA-125 in a 21-year-old female
por: Purwar, Roli, et al.
Publicado: (2022) -
TFE3-associated perivascular epithelioid cell tumor with complete response to mTOR inhibitor therapy: report of first case and literature review
por: Purwar, Roli, et al.
Publicado: (2022) -
Cancer surgery during COVID increased the patient mortality and the transmission risk to healthcare workers: results from a retrospective cohort study (NCT05240378)
por: Soni, Kishan, et al.
Publicado: (2022) -
Neoadjuvant strategies in resectable carcinoma esophagus: a meta-analysis of randomized trials
por: Kumar, Tarun, et al.
Publicado: (2020)